Paul Hastings Advised Stifel as Book-Running Manager on Precigen’s Common Stock Offering
Paul Hastings advised Stifel as the sole book-running manager in connection with Precigen, Inc.’s underwritten public offering of common stock. The offering is expected to close on August 9, 2024, subject to customary closing conditions.
Co-head of Equity Capital Markets and Co-chair of the Corporate Life Sciences Group Seo Salimi and Securities and Capital Markets partner Will Magioncalda led the Paul Hastings team, which also included associates Lauren Zhang and Adam Swank.
More details can be found here.
With widely recognized elite teams across 17 core practices, Paul Hastings is a premier law firm with a culture of excellence focused on providing intellectual capital and superior execution globally to the world's leading investment banks, asset managers and corporations.